pantoprazole has been researched along with Enterocolitis in 1 studies
Pantoprazole: 2-pyridinylmethylsulfinylbenzimidazole proton pump inhibitor that is used in the treatment of GASTROESOPHAGEAL REFLUX and PEPTIC ULCER.
pantoprazole : A member of the class of benzimidazoles that is 1H-benzimidazole substituted by a difluoromethoxy group at position 5 and a [(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl group at position 2.
Enterocolitis: Inflammation of the MUCOSA of both the SMALL INTESTINE and the LARGE INTESTINE. Etiology includes ISCHEMIA, infections, allergic, and immune responses.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bouvette, G | 1 |
| Verreault, N | 1 |
| Gagnon, N | 1 |
| Lavoie, A | 1 |
1 other study available for pantoprazole and Enterocolitis
| Article | Year |
|---|---|
Drug-induced enterocolitis syndrome (DIES) with pantoprazole in an adult patient.
Topics: Adult; Enterocolitis; Humans; Pantoprazole; Pharmaceutical Preparations; Proton Pump Inhibitors; Syn | 2020 |